medpharm holdco limited
medpharm holdco limited Company Information
Company Number
11234758
Next Accounts
142 days late
Shareholders
ampersand 2023 limited partnership
ampersand 2014 limited partnership
View AllGroup Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
unit 3, chancellor court, 50 occam road, guildford, GU2 7AB
Website
http://www.medpharm.commedpharm holdco limited Estimated Valuation
Pomanda estimates the enterprise value of MEDPHARM HOLDCO LIMITED at £40.5m based on a Turnover of £18.7m and 2.17x industry multiple (adjusted for size and gross margin).
medpharm holdco limited Estimated Valuation
Pomanda estimates the enterprise value of MEDPHARM HOLDCO LIMITED at £0 based on an EBITDA of £-11.3m and a 9x industry multiple (adjusted for size and gross margin).
medpharm holdco limited Estimated Valuation
Pomanda estimates the enterprise value of MEDPHARM HOLDCO LIMITED at £0 based on Net Assets of £-12.5m and 1.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medpharm Holdco Limited Overview
Medpharm Holdco Limited is a live company located in guildford, GU2 7AB with a Companies House number of 11234758. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in March 2018, it's largest shareholder is ampersand 2023 limited partnership with a 48.4% stake. Medpharm Holdco Limited is a young, mid sized company, Pomanda has estimated its turnover at £18.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medpharm Holdco Limited Health Check
Pomanda's financial health check has awarded Medpharm Holdco Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £18.7m, make it in line with the average company (£18m)
£18.7m - Medpharm Holdco Limited
£18m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (6.4%)
8% - Medpharm Holdco Limited
6.4% - Industry AVG
Production
with a gross margin of 59.3%, this company has a lower cost of product (36.2%)
59.3% - Medpharm Holdco Limited
36.2% - Industry AVG
Profitability
an operating margin of -80.2% make it less profitable than the average company (5.3%)
-80.2% - Medpharm Holdco Limited
5.3% - Industry AVG
Employees
with 182 employees, this is above the industry average (104)
182 - Medpharm Holdco Limited
104 - Industry AVG
Pay Structure
on an average salary of £62.4k, the company has a higher pay structure (£41.9k)
£62.4k - Medpharm Holdco Limited
£41.9k - Industry AVG
Efficiency
resulting in sales per employee of £102.6k, this is less efficient (£178.7k)
£102.6k - Medpharm Holdco Limited
£178.7k - Industry AVG
Debtor Days
it gets paid by customers after 49 days, this is near the average (47 days)
49 days - Medpharm Holdco Limited
47 days - Industry AVG
Creditor Days
its suppliers are paid after 85 days, this is slower than average (47 days)
85 days - Medpharm Holdco Limited
47 days - Industry AVG
Stock Days
it holds stock equivalent to 5 days, this is less than average (43 days)
5 days - Medpharm Holdco Limited
43 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (16 weeks)
5 weeks - Medpharm Holdco Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 168.8%, this is a higher level of debt than the average (69.5%)
168.8% - Medpharm Holdco Limited
69.5% - Industry AVG
MEDPHARM HOLDCO LIMITED financials
Medpharm Holdco Limited's latest turnover from December 2022 is £18.7 million and the company has net assets of -£12.5 million. According to their latest financial statements, Medpharm Holdco Limited has 182 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|
| Turnover | 18,676,309 | 19,411,175 | 17,930,218 | 14,992,435 | 10,964,455 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 7,601,179 | 5,965,524 | 5,467,913 | 4,792,184 | 6,016,448 |
| Gross Profit | 11,075,130 | 13,445,651 | 12,462,305 | 10,200,251 | 4,948,007 |
| Admin Expenses | 26,049,101 | 14,226,896 | 12,749,905 | 11,669,383 | 4,805,906 |
| Operating Profit | -14,973,971 | -781,245 | -287,600 | -1,469,132 | 142,101 |
| Interest Payable | 1,334,784 | 1,084,264 | 1,013,310 | 14,531 | 14,034 |
| Interest Receivable | 1,270 | 19 | 472 | 31,604 | 11,839 |
| Pre-Tax Profit | -16,307,485 | -1,865,490 | -1,300,438 | -1,452,059 | 139,906 |
| Tax | -497,108 | -355,994 | -328,052 | -138,425 | -205,665 |
| Profit After Tax | -16,804,593 | -2,221,484 | -1,628,490 | -1,590,484 | -65,759 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -16,804,593 | -2,221,484 | -1,628,490 | -1,590,484 | -65,759 |
| Employee Costs | 11,364,585 | 10,747,473 | 10,138,923 | 8,406,592 | 5,354,037 |
| Number Of Employees | 182 | 165 | 145 | 146 | 126 |
| EBITDA* | -11,299,001 | 2,077,860 | 2,422,146 | 839,845 | 1,917,016 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|
| Tangible Assets | 10,262,960 | 10,623,607 | 6,738,606 | 4,282,409 | 2,498,255 |
| Intangible Assets | 0 | 10,583,967 | 12,290,000 | 14,018,925 | 15,681,551 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 42,415 | 2,074 | 2,074 | 0 |
| Total Fixed Assets | 10,262,960 | 21,165,159 | 19,026,532 | 18,301,334 | 18,179,806 |
| Stock & work in progress | 108,583 | 0 | 0 | 0 | 0 |
| Trade Debtors | 2,511,034 | 3,044,850 | 3,397,449 | 3,206,873 | 2,956,484 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 3,957,782 | 5,526,266 | 3,599,329 | 2,367,214 | 2,533,741 |
| Cash | 1,363,707 | 1,138,947 | 622,226 | 2,960,057 | 4,823,752 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 7,941,106 | 9,710,063 | 7,619,004 | 8,534,144 | 10,313,977 |
| total assets | 18,204,066 | 30,875,222 | 26,645,536 | 26,835,478 | 28,493,783 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 5,836,937 | 3,325,451 | 0 | 0 | 0 |
| Trade Creditors | 1,770,417 | 1,508,950 | 731,960 | 780,773 | 634,654 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 6,635 | 70,542 | 66,672 | 65,864 | 64,162 |
| other current liabilities | 4,449,767 | 4,922,064 | 4,062,931 | 3,959,272 | 4,358,834 |
| total current liabilities | 12,063,756 | 9,827,007 | 4,861,563 | 4,805,909 | 5,057,650 |
| loans | 17,297,260 | 16,320,956 | 15,460,606 | 306,266 | 451,682 |
| hp & lease commitments | 6,634 | 11,848 | 81,673 | 153,133 | 225,841 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 |
| provisions | 1,366,441 | 2,046,932 | 1,255,278 | 729,488 | 487,124 |
| total long term liabilities | 18,670,335 | 17,332,574 | 16,006,572 | 517,877 | 469,403 |
| total liabilities | 30,734,091 | 27,159,581 | 20,868,135 | 5,323,786 | 5,527,053 |
| net assets | -12,530,025 | 3,715,641 | 5,777,401 | 21,511,692 | 22,966,730 |
| total shareholders funds | -12,530,025 | 3,715,641 | 5,777,401 | 21,511,692 | 22,966,730 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | -14,973,971 | -781,245 | -287,600 | -1,469,132 | 142,101 |
| Depreciation | 1,968,937 | 1,153,072 | 980,821 | 631,186 | 411,302 |
| Amortisation | 1,706,033 | 1,706,033 | 1,728,925 | 1,677,791 | 1,363,613 |
| Tax | -497,108 | -355,994 | -328,052 | -138,425 | -205,665 |
| Stock | 108,583 | 0 | 0 | 0 | 0 |
| Debtors | -2,144,715 | 1,614,679 | 1,422,691 | 85,936 | 5,490,225 |
| Creditors | 261,467 | 776,990 | -48,813 | 146,119 | 634,654 |
| Accruals and Deferred Income | -472,297 | 859,133 | 103,659 | -399,562 | 4,358,834 |
| Deferred Taxes & Provisions | -680,491 | 791,654 | 525,790 | 242,364 | 487,124 |
| Cash flow from operations | -10,651,298 | 2,534,964 | 1,252,039 | 604,405 | 1,701,738 |
| Investing Activities | |||||
| capital expenditure | 0 | ||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | ||||
| Financing Activities | |||||
| Bank loans | 2,511,486 | 3,325,451 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 976,304 | 860,350 | 15,154,340 | -145,416 | 451,682 |
| Hire Purchase and Lease Commitments | -69,121 | -65,955 | -70,652 | -71,006 | 290,003 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||
| interest | -1,333,514 | -1,084,245 | -1,012,838 | 17,073 | -2,195 |
| cash flow from financing | 2,644,082 | 3,195,325 | -34,951 | -63,903 | 23,771,979 |
| cash and cash equivalents | |||||
| cash | 224,760 | 516,721 | -2,337,831 | -1,863,695 | 4,823,752 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 224,760 | 516,721 | -2,337,831 | -1,863,695 | 4,823,752 |
medpharm holdco limited Credit Report and Business Information
Medpharm Holdco Limited Competitor Analysis
Perform a competitor analysis for medpharm holdco limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mid companies, companies in GU2 area or any other competitors across 12 key performance metrics.
medpharm holdco limited Ownership
MEDPHARM HOLDCO LIMITED group structure
Medpharm Holdco Limited has 1 subsidiary company.
medpharm holdco limited directors
Medpharm Holdco Limited currently has 4 directors. The longest serving directors include Mr Trevor Wahlbrink (Mar 2018) and Mr David Parker (Mar 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Trevor Wahlbrink | United States | 41 years | Mar 2018 | - | Director |
| Mr David Parker | United Kingdom | 64 years | Mar 2018 | - | Director |
| Mr Edward Hjerpe | 34 years | Jun 2024 | - | Director | |
| Mr Patrick Walsh | 64 years | Oct 2024 | - | Director |
P&L
December 2022turnover
18.7m
-4%
operating profit
-15m
+1817%
gross margin
59.4%
-14.39%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-12.5m
-4.37%
total assets
18.2m
-0.41%
cash
1.4m
+0.2%
net assets
Total assets minus all liabilities
medpharm holdco limited company details
company number
11234758
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
March 2018
age
7
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
RSM UK AUDIT LLP
address
unit 3, chancellor court, 50 occam road, guildford, GU2 7AB
Bank
-
Legal Advisor
-
medpharm holdco limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to medpharm holdco limited. Currently there are 1 open charges and 2 have been satisfied in the past.
medpharm holdco limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDPHARM HOLDCO LIMITED. This can take several minutes, an email will notify you when this has completed.
medpharm holdco limited Companies House Filings - See Documents
| date | description | view/download |
|---|
